Phase 1 Study of MK-1084 in KRAS mutant advanced solid tumors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501563-40-00

Acronym

MK-1084-001

Enrollment

115

Registered

2023-09-07

Start date

2021-12-16

Completion date

Unknown

Last updated

2025-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumor cancer and lung cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark, France, Italy, Lithuania, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026